SAD Study in Patients With Parkinson's Disease and Motor Fluctuations

NCT07422675 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

PARKINSON DISEASE (Disorder)
Advanced Parkinson's Disease

Interventions

DRUG: SER-252 (PEOZ-apomorphine)
DEVICE: enFuse

Sponsor

Serina Therapeutics